Thoratec CEO Recollects HeartMate Reimbursement Planning Experience
This article was originally published in The Gray Sheet
Executive Summary
Device companies seeking national coverage decisions should initiate discussions with CMS concerning the economic impact of their new technology, according to Thoratec President & CEO Keith Grossman